Koninklijke Philips | PHG - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Danaher USD 3.61B 20M 2026-06
Demant DKK 9.96B 1.13B 2026-06
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Fresenius EUR 1.55B 16M 2026-06
General Electric Aerospace USD 4.46B 220M 2026-06
Getinge SEK 4.42B 638M 2026-06
Globus Medical USD 548.17M 51.91M 2026-06
GN Store Nord DKK 1.13B 116M 2026-06
Hitachi JPY 809.67B 134.97B 2026-06
Idexx Laboratories USD 779.09M 56.35M 2026-06
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
J&J USD 18.55B 1.31B 2026-06
Koninklijke Philips EUR 1.77B 522M 2026-03
Medtronic USD 6.36B 355M 2026-06
Philips EUR 2.15B 384M 2026-06
ResMed USD 861.22M 29.76M 2026-06
Smith & Nephew USD 2.09B 117M 2025-12
Steris USD 684.2M 12.9M 2026-06
Stryker USD 4.5B 688M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
Terumo JPY 178.54B 29.52B 2026-06
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06